group reported STING ADC (αEGFR-172ADC) for their molecule IMSA172 that demonstrated potent antitumor efficacy in-vivo and promoted activation of dendritic cells, T cells, natural killer cells, natural killer T cells, as well as promotion of M2 to M1 polarization of tumor-associated macrophages. Here, STING1 is linked to neoplasm.